Apricus Biosciences Announces National Phase Approval for Vitaros in Spain
April 24, 2014 at 08:08 AM EDT
Apricus Biosciences, Inc. (Nasdaq: APRI), a pharmaceutical company focusing on the development and commercialization of novel ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.